Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
Keywords: کارسینوم کلیوی; Therapy sequence; Tyrosine kinase inhibitor; Sorafenib; Sunitinib; Renal carcinoma; Second line